Memphis Pharmaceuticals & Chemical Industries (EGX:MPCI)

Egypt flag Egypt · Delayed Price · Currency is EGP
168.11
-3.99 (-2.32%)
At close: Dec 4, 2025
236.15%
Market Cap 3.82B
Revenue (ttm) 1.61B
Net Income (ttm) 517.39M
Shares Out 22.75M
EPS (ttm) 22.74
PE Ratio 7.39
Forward PE n/a
Dividend 13.19 (7.84%)
Ex-Dividend Date Oct 27, 2025
Volume 444,492
Average Volume 351,219
Open 172.10
Previous Close 172.10
Day's Range 168.00 - 173.90
52-Week Range 47.15 - 232.95
Beta 0.09
RSI 41.20
Earnings Date Nov 12, 2025

About EGX:MPCI

Memphis Pharmaceuticals & Chemical Industries, a drug holding company, produces and sells pharmaceutical products for human and veterinary use in Egypt and internationally. The company offers human health products in various therapeutic areas, including anti-infective, CNS, dermatological, cardio vascular system, corticosteroid, vitamins and minerals, musculo-skeletal system, analgesic and antipyretic, respiratory system, genitourinary system, alimentary tract and metabolism, antihistaminic, antiparasites, and hormones. It also provides animal ... [Read more]

Industry Pharmaceutical Preparations
Founded 1940
Employees 144
Stock Exchange Egyptian Stock Exchange
Ticker Symbol MPCI
Full Company Profile

Financial Performance

In 2025, EGX:MPCI's revenue was 1.51 billion, an increase of 72.93% compared to the previous year's 871.91 million. Earnings were 505.28 million, an increase of 163.91%.

Financial Statements

News

There is no news available yet.